NASDAQ$NKTX

Nkarta Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

Nkarta reported Q1 2025 a net loss of $32.0M, diluted EPS of $-0.43.

For Q1 2025, Nkarta reported net loss was $32.0M, diluted EPS was $-0.43. The quarterly filing discusses operating priorities, liquidity, and sector-specific risks in MD&A.

  • Net loss $32.0M.
  • Diluted EPS $-0.43.
  • MD&A highlights cash runway, pipeline progress, and macro risks.

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS (adj)

-$0.43

Previous: -$0.58+25.9%
R&D Expenses

$24.2M

Previous: $25.2M-4.2%
G&A Expenses

$12.4M

Previous: $7.53M+64.7%
Net Loss Per Share (Basic & Diluted)

-$0.43

Previous: -$0.58+25.9%
Total Operating Expenses

$36.6M

Previous: $32.8M+11.6%
Interest Income

$4.38M

Previous: $3.25M+34.8%
Other Income, Net

$205K

Previous: -$2K+10350.0%
Total Other Income, Net

$4.58M

Previous: $3.24M+41.2%
Weighted Average Shares Outstanding

73.9M

Previous: 50.7M+45.8%
Non-cash Stock-based Comp. (R&D)

$1.1M

No prior period
Non-cash Stock-based Comp. (G&A)

$1.7M

No prior period
Restructuring Expenses (G&A)

$5.1M

No prior period
Net Loss Non-Cash Charges

$4.3M

No prior period
Capital Expenditures

-$518K

Previous: -$175K-196.0%
Net Income

-$32M

Previous: -$29.5M-8.4%
Operating Income

-$36.6M

Previous: -$32.8M-11.6%

Revenue & EPS history

Nkarta · Revenue · Quarterly

$0

Q1 2025

Forward guidance

Outlook emphasizes clinical milestones, cash runway, and operating expense discipline.

Tailwinds

  • Pipeline progress and partnership optionality.
  • Cost controls and balance-sheet flexibility.

Headwinds

  • Operating losses until commercialization.
  • Trial timing and regulatory uncertainty.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.9%

Avg return

Earnings day

-2.2%

Avg return

5 days after

-0.9%

Avg return

30 days after

63%

15 / 24 earnings

Positive

+16.2%

Q4 2021

Best reaction

-30.3%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+0.9%-14.8%
Q1 2026+3.5%-16.1%-13.2%
Q3 2025+3.1%-4.6%-4.6%
Q2 2025+12.8%+19.9%+0.5%
Q1 2025+1.2%-0.6%-4.6%
Q4 2024+3.2%-15.4%+13.3%
Q3 2024-4.8%-9.0%-23.0%
Q2 2024+1.2%+0.0%+10.3%
Q1 2024-2.3%+2.3%+3.1%
Q4 2023-30.3%-22.8%-43.0%
Q3 2023-5.6%+7.0%+27.0%
Q2 2023-0.5%-1.0%-20.5%
Q1 2023-4.1%-4.1%-0.9%
Q4 2022+1.3%-7.1%+19.3%
Q3 2022-8.4%-2.1%-35.5%
Q2 2022+8.8%+11.1%-8.5%
Q1 2022+12.8%+11.1%+6.9%
Q4 2021+16.2%+6.2%-15.2%
Q3 2021+7.7%+7.2%-15.0%
Q2 2021-1.9%-5.0%-29.0%
Q4 2020+0.0%-14.4%-30.3%
Q3 2020+2.9%+14.5%+122.0%
Q2 2020-7.0%-12.0%+21.1%
Q1 2021+11.3%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro